The Prospective Italian Registry of SCS evaluated the clinical outcomes of patients with severe, treatment-refractory angina who underwent implantation of a spinal cord stimulation device.
Of the 104 patients enrolled in the registry, 70 were men; the mean age was 68 ± 17 years. Eighty-three percent had severe coronary artery disease.
During the observation period
17 (16%) patients country wise email marketing list died, including 2 from cardiac death.
Spinal cord stimulation improved angina symptoms (greater than 50% reduction in weekly angina episodes) in 73% of patients.
Eighty percent of patients improved by one or more Canadian Cardiovascular Society Angina Class (CCS) class, and 42% of patients improved by two or more classes.
Spinal cord stimulation also reduced the rate of hospitalizations and days of hospital stay due to angina (p<0.0001).
The most common side effect of stimulation was superficial taiwan lists infections and was observed in six patients.
No serious adverse reactions associated with the procedure were observed. (Xagena2003)
an invasive strategy is associated with increased 1-year survival.
The aim of the study was to verify
Whether early catheterization could reduce mortality in patients with in patients with acute coronary syndromes unstable angina and non-ST-segment elevation myocardial infarction.
Data collected in the GUSTO IIb study were retrospectively analyzed.
7,897 patients with unstable angina and non-ST-segment Therefore, elevation myocardial infarction were identified.
Of these, 57% (n=4,536) underwent invasive therapy and 43% (n=3,361) underwent conservative therapy.
The primary endpoint was all-cause mortality at 30 days and 1 year.